Ipamorelin Peptide Guide

What is Ipamorelin?

Ipamorelin is a small, lab-designed peptide in the “growth hormone secretagogue” family. Instead of replacing hormones, it signals through the ghrelin receptor (also called the GHS receptor) to prompt the pituitary to release growth hormone in a time-limited pulse. This matters because GH is naturally released in bursts (especially around sleep), and secretagogues are often studied as a way to support that pattern rather than creating continuous hormone exposure.

Educational information only. Not medical advice.

Benefits

• A short, time-limited GH pulse (the most consistent measurable effect in research settings)
• Potential improvements in sleep depth/quality (reported commonly, but varies)
• Recovery support between training sessions (often described as less soreness or better readiness)
• Possible body composition support through GH-linked fat mobilization (less certain)

Mechanism of action

Primary pathways (studied):

• GHSR-1a (ghrelin receptor) activation in hypothalamus/pituitary
• Increased pulsatile GH release (single, time-limited episode after exposure)
• Downstream GH → IGF-1 axis signaling (context-dependent; varies by exposure pattern and individual physiology)

Cell-level effects (studied):

• Stimulates somatotroph signaling that increases GH secretion
• Bias toward GH release with comparatively reduced ACTH/cortisol response versus some older GHRPs (based on comparative pharmacology)
• May influence autonomic and gut motility pathways through ghrelin-receptor signaling (basis for GI research programs)

System-level effects (studied):

• Short-lived GH pulse with downstream effects on recovery signaling and substrate use
• Potential shifts in fluid balance and connective tissue turnover consistent with GH signaling (variable, not guaranteed)
• Possible effects on appetite and GI motility (typically less “hunger signaling” reported than some other GHRPs, but not absent)

Half-life

Half-life: Approximately ~2 hours reported in a controlled human IV infusion study; not fully established across routes and real-world use.

Duration: Time-limited GH pulse; GH elevations generally taper back toward baseline over hours rather than persisting all day.

Peak time: GH response peak reported around ~0.7 hours after exposure in controlled human PK/PD work (timing varies by study design and route).

Storage

Storage depends on formulation (lyophilized powder vs reconstituted solution) and the manufacturer. Follow the product label when available.

• Dry / lyophilized: commonly kept cool, dry, and protected from light.
• Reconstituted: commonly refrigerated and used within the supplier’s stated window.
• Avoid: repeated heat exposure and unnecessary freeze–thaw cycles.

Reconstitution guide

For measurement math (mg, mL, and U-100 units), use:

• Peptide reconstitution guide
• Peptide reconstitution calculator

Protocol overview

Protocol pages summarize common research-style structures and measurement concepts. They do not provide individualized instructions.

Educational information only. Not medical advice.

Research review and sources

Key research takeaways surfaced on this page

• Research context available in the underlying profile.
• Research context available in the underlying profile.
• Research context available in the underlying profile.

Related tools

Use these tools and guides together for research and education.

Suggested links

• CJC-1295 Peptide Guide
• Peptide Half-Life Chart: Reference for Research
• Growth Hormone Stack (CJC-1295/Ipamorelin + IGF-1 LR3)